Menu

rss
Evid Based Nurs 15:90-91 doi:10.1136/ebnurs-2012-100551
  • Primary health care
  • Randomised controlled trial

Vitamin E increases prostate cancer risk in middle-aged men relative to placebo: no significant association observed with selenium, either alone or in combination with vitamin E

  1. Gwen Wyatt
  1. College of Nursing, Michigan State University, East Lansing, Michigan, USA
  1. Correspondence to Gwen Wyatt
    College of Nursing, Michigan State University, 515 W Fee Hall, East Lansing, MI 48824, USA; gwen.wyatt{at}hc.msu.edu

Commentary on: Klein EA, Thompson IM Jr., Tangen CM, et al. Vitamin E and the risk of prostate cancer: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2011;306:1549–56.

Implications for practice and research

  • ■ Clinicians should inform patients that vitamin E significantly increased the risk of prostate cancer among healthy men, and should be avoided.

  • ■ Extended follow-up of common doses of vitamins and supplements may reveal new and critically significant findings.

Context

The lifetime risk for prostate cancer in the USA is currently estimated to be 16%. The objective of this study was to determine the long-term effect of vitamin E and selenium on the risk of prostate cancer in healthy men who had participated in the …

[Full text of this article]

This Article

  1. Extract
  2. Full text
  3. PDF
  4. All Versions of this Article:
    1. ebnurs-2012-100551v1
    2. 15/3/90 most recent

Responses

  1. Submit a response
  2. No responses published

Social bookmarking

EBN Twitter Journal Club

The club runs like other journal discussion groups, except that the article and questions are posted on this blog and the discussion about the article happens on Twitter.

How to participate >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.